Insiders · TVGN

TVGN insider transactions

Tevogen Inc. (TVGN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

TVGN insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Tevogen Inc., latest first. Follow anyone to get their next filing.

• Ryan H. SaadiChief Executive Officer, Director, 10% owner, since February 2024+$2,000-$1.77M
• Kirti DesaiChief Financial Officer, since February 2024+$2,460
• Keow Lin GohDirector, since February 2024
• Susan M PodlogarDirector, since February 2024
• Victor J. SordilloDirector, since February 2024
• Jeffrey L. FeikeDirector, since February 2024
• Curtis L. PattonDirector, since February 2024
• Neal FlomenbergChief Scientific Officer, since February 2024-$2.49M
• Sadiq KhanChief Commercial Officer, since February 2024
• Corbin Capital Partners, L.P.10% owner, since February 2023-$24.8M
• Surendra K AjjarapuOfficer, Director, 10% owner, since June 2023
• SSVK Associates, LLC10% owner, since June 2023
• Scott Harris SussmanDirector, since June 2023
• Avinash R WadhwaniDirector, since June 2023
• Michael L PetersonDirector, since June 2023
• Knuettel Francis IIOfficer, since June 2023
• Donald G. FellDirector, since June 2023
• Semper Paratus Sponsor LLC10% owner-$8.99M

Recent Form 3, 4, and 5 filings for TVGN

• 10d
  Chief Executive Officer Saadi Ryan H. was granted 50,000,000 shares, increasing direct ownership by 427% to 61,705,689 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 59d
  Chief Executive Officer Saadi Ryan H. was granted 8,000,000 shares, increasing direct ownership by 216% to 11,705,689 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 59d
  Chief Financial Officer Desai Kirti was granted 750,000 shares, increasing direct ownership by 309% to 992,983 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 60d
  Director Goh Keow Lin was granted 75,000 shares, increasing direct ownership by 154% to 123,678 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 60d
  Director Podlogar Susan M was granted 75,000 shares, increasing direct ownership by 154% to 123,678 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 60d
  Director Sordillo Victor J. was granted 75,000 shares, increasing direct ownership by 146% to 126,539 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 60d
  Director Feike Jeffrey L. was granted 75,000 shares, increasing direct ownership by 133% to 131,435 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 60d
  Director Patton Curtis L. was granted 75,000 shares, increasing direct ownership by 117% to 139,192 units (SEC Form 4)

  4 - Tevogen Inc. (0001860871) (Issuer)
• 127d
  Director Sordillo Victor J. was granted 40,000 shares, increasing direct ownership by 347% to 51,539 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Chief Executive Officer Saadi Ryan H. was granted 1,220,000 shares, increasing direct ownership by 49% to 3,705,689 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Director Podlogar Susan M was granted 40,000 shares, increasing direct ownership by 461% to 48,678 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Director Patton Curtis L. was granted 40,000 shares, increasing direct ownership by 165% to 64,192 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Director Goh Keow Lin was granted 40,000 shares, increasing direct ownership by 461% to 48,678 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Director Feike Jeffrey L. was granted 40,000 shares, increasing direct ownership by 243% to 56,435 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 127d
  Chief Financial Officer Desai Kirti was granted 40,000 shares, increasing direct ownership by 20% to 242,983 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 242d
  Officer Flomenberg Neal sold $6,635 worth of shares (972 units at $6.83), decreasing direct ownership by 1% to 76,940 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 327d
  Chief Executive Officer Saadi Ryan H. gifted 50,000 shares, decreasing direct ownership by 0.04% to 124,284,453 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 334d
  Chief Financial Officer Desai Kirti gifted 300,000 shares, decreasing direct ownership by 3% to 10,149,186 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 337d
  Chief Executive Officer Saadi Ryan H. gifted 460,000 shares, decreasing direct ownership by 0.37% to 124,334,453 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 453d
  Chief Executive Officer Saadi Ryan H. gifted 20,000 shares, decreasing direct ownership by 0.02% to 124,794,453 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 501d
  Chief Executive Officer Saadi Ryan H. was granted 8,000,000 shares, increasing direct ownership by 7% to 124,814,453 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 501d
  Chief Commercial Officer Khan Sadiq was granted 200,000 shares, increasing direct ownership by 21% to 1,169,618 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 501d
  Chief Financial Officer Desai Kirti was granted 750,000 shares, increasing direct ownership by 8% to 10,449,186 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 501d
  Officer Flomenberg Neal was granted 300,000 shares, increasing direct ownership by 8% to 3,895,608 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 523d
  Chief Executive Officer Saadi Ryan H. sold $1,768,993 worth of shares (1,438,206 units at $1.23), decreasing direct ownership by 1% to 116,814,453 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 610d
  Officer Flomenberg Neal sold $253,935 worth of shares (232,968 units at $1.09), decreasing direct ownership by 6% to 3,595,608 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 613d
  Officer Flomenberg Neal sold $231,734 worth of shares (211,909 units at $1.09), decreasing direct ownership by 5% to 3,828,576 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 618d
  Officer Flomenberg Neal sold $250,006 worth of shares (213,817 units at $1.17), decreasing direct ownership by 5% to 4,040,485 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 688d
  Director Feike Jeffrey L. was granted 240,000 shares, increasing direct ownership by 41% to 821,771 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 688d
  Director Patton Curtis L. was granted 240,000 shares, increasing direct ownership by 25% to 1,209,618 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 688d
  Director Podlogar Susan M was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 688d
  Director Sordillo Victor J. was granted 480,000 shares, increasing direct ownership by 495% to 576,962 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 688d
  Director Goh Keow Lin was granted 240,000 shares, increasing direct ownership by 124% to 433,923 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 757d
  Officer Flomenberg Neal sold $1,747,332 worth of shares (1,078,600 units at $1.62), decreasing direct ownership by 20% to 4,254,302 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 884d
  Chief Financial Officer Desai Kirti bought $2,460 worth of shares (3,000 units at $0.82), increasing direct ownership by 0.03% to 9,699,186 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)
• 890d
  Saadi Ryan H. bought $2,000 worth of shares (2,607 units at $0.77), increasing direct ownership by 0.00% to 118,252,659 units (SEC Form 4)

  4 - Tevogen Bio Holdings Inc. (0001860871) (Issuer)